Cargando…
Modulation of Reoviral Cytolysis (II): Cellular Stemness
Oncolytic viruses (OVs) are an emerging cancer therapeutic that are intended to act by selectively targeting and lysing cancerous cells and by stimulating anti-tumour immune responses, while leaving normal cells mainly unaffected. Reovirus is a well-studied OV that is undergoing advanced clinical tr...
Autores principales: | Bourhill, Tarryn, Rohani, Leili, Kumar, Mehul, Bose, Pinaki, Rancourt, Derrick, Johnston, Randal N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386201/ https://www.ncbi.nlm.nih.gov/pubmed/37515162 http://dx.doi.org/10.3390/v15071473 |
Ejemplares similares
-
Going (Reo)Viral: Factors Promoting Successful Reoviral Oncolytic Infection
por: Bourhill, Tarryn, et al.
Publicado: (2018) -
Modulation of Reoviral Cytolysis (I): Combination Therapeutics
por: Mori, Yoshinori, et al.
Publicado: (2023) -
Concise Review: Molecular Cytogenetics and Quality Control: Clinical Guardians for Pluripotent Stem Cells
por: Rohani, Leili, et al.
Publicado: (2018) -
Enhanced Osteogenic Differentiation of Pluripotent Stem Cells via γ-Secretase Inhibition
por: Helmi, Summer A., et al.
Publicado: (2021) -
Energy metabolism and T-cell-mediated cytolysis. II. Selective inhibition of cytolysis by 2-deoxy-D-glucose
Publicado: (1977)